MRI scan
DeviceAll participants underwent the MRI scan
NCT Number: NCT03439163
Resting-state functional magnetic resonance imaging (RS-fMRI) has frequently been used to investigate local spontaneous brain activity in Parkinson's disease (PD) in a whole-brain, voxel-wise manner. To quantitatively integrate these studies, we conducted a coordinate-based meta-analysis on 15 studies that used amplitude of low frequency fluctuation (ALFF) and 11 studies that used regional homogeneity (ReHo). All these ALFF and ReHo studies have compared PD patients with healthy controls. We also performed a validation RS-fMRI study of ALFF and ReHo in a frequency-dependent manner for a novel dataset consisting of PD and healthy controls.
Looking for future studies?
Notify Me50 year–70 year
All sexes
Observational
Seed-based d Mapping (formerly Signed Differential Mapping, SDM) software (version 5.141 for Windows) (www.sdmproject.com) was used for meta-analysis.
For the validation, fMRI data were acquired on a 3 Tesla Magnetic Resonance scanner (Trio system; Siemens Magnetom scanner, Erlangen, Germany) with gradient-echo echo-plannar imaging sequences. Whole brain fMRI scanning was carried out. All participants were instructed to keep their eyes closed, relax, remain motionless, not think of anything in particular, and not fall asleep. Foam pads were used to minimize head motion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All participants underwent the MRI scan
Time frame: 06/2015-01/2016
We found a decreased spontaneous brain activity in left putamen in PD patients
Xuanwu Hospital, Beijing
Other
Large Sample Collection for Observation of PD Patients and Healthy Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04863859
Alzheimer Disease, Brain Diseases
Blacksburg, Virginia, United States
View Trial DetailsNCT07244900
Basal Ganglia Diseases, Brain Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05733494
Deglutition Disorders, Digestive System Diseases
Milan, Milano, Italy
View Trial DetailsNCT06625710
Neuro-Degenerative Disease
Seoul, South Korea
View Trial Details